Sign in

Iris Finci

@fincika.bsky.social
819 followers 188 following 3 posts

Infectious disease epidemiologist @ WHO Euro EPIET alumna

PostsRepliesMedia
Iris Finci @fincika.bsky.social · 14/02/2025
What a short-sighted move! www.statnews.com/2025/02/14/t...
statnews.com
CDC cuts expected to devastate Epidemic Intelligence Service, a ‘crown jewel’ of public health
Members of the CDC's Epidemic Intelligence Service were warned Friday that many of them were about to be fired
010
Iris Finci @fincika.bsky.social · 30/01/2025
www.afro.who.int/countries/ug...
afro.who.int
WHO accelerates efforts to support response to Sudan virus disease outbreak in Uganda
Brazzaville/Kampala – Following the confirmation of an outbreak of Sudan virus disease – which belongs to the same family as Ebola virus disease – in Uganda today, World Health Organization (WHO) is m...
012
Reposted by Iris Finci
Saloni @scientificdiscovery.dev · 30/01/2025
AMFAR has published a report on how the foreign aid freeze affects PEPFAR, which actually still hasn't resumed. They estimate that hundreds of thousands of people lose access to HIV antivirals and 1500 babies are expected to contract HIV — *each day* 🧵
12444244
Iris Finci @fincika.bsky.social · 29/01/2025
State Department Permits Distribution of H.I.V. Medications to Resume — for Now www.nytimes.com/2025/01/28/h...
nytimes.com
State Department Permits Distribution of H.I.V. Medications to Resume — for Now
Experts fear a resurgence of infections in low-income countries if the ban were to continue. The waiver remains in place, while officials review foreign aid programs.
000
Reposted by Iris Finci
Science Magazine @science.org · 12/12/2024
Science’s 2024 Breakthrough of the Year is lenacapavir, an injectable drug that demonstrated remarkable success at preventing HIV infection with one shot every 6 months. Learn more about this year's #BOTY and other big advances in science: scim.ag/3BrCtUn
Science’s 2024 Breakthrough of the Year is lenacapavir, an injectable drug that demonstrated remarkable success at preventing HIV infection with one shot every 6 months. The drug attaches to the lattice-like capsid proteins that shield the virus’s genetic material—a mechanism that could inspire other antivirals. Lenacapavir could help end the HIV/AIDS epidemic, but that will hinge on access for those who need it most.
20421160